Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

728 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of acute C hepatitis in HIV-infected patients.
Audagnotto S, De Rosa FG, Bargiacchi O, Garazzino S, Veronese L, Cariti G, Di Perri G. Audagnotto S, et al. Among authors: di perri g. J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):110-1. doi: 10.1097/01.qai.0000174648.43461.41. J Acquir Immune Defic Syndr. 2005. PMID: 16123692 Clinical Trial. No abstract available.
Acute hepatitis C: dosage and compliance.
De Rosa F, Cariti G, Di Perri G. De Rosa F, et al. Among authors: di perri g. Hepatology. 2006 Aug;44(2):511; author reply 511-2. doi: 10.1002/hep.21273. Hepatology. 2006. PMID: 16871564 No abstract available.
Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group.
Svicher V, D'Arrigo R, Alteri C, Andreoni M, Angarano G, Antinori A, Antonelli G, Bagnarelli P, Baldanti F, Bertoli A, Borderi M, Boeri E, Bonn I, Bruzzone B, Callegaro AP, Cammarota R, Canducci F, Ceccherini-Silberstein F, Clementi M, Monforte AD, De Luca A, Di Biagio A, Di Gianbenedetto S, Di Perri G, Di Pietro M, Fabeni L, Fadda G, Galli M, Gennari W, Ghisetti V, Giacometti A, Gori A, Leoncini F, Maggiolo F, Maserati R, Mazzotta F, Micheli V, Meini G, Monno L, Mussini C, Nozza S, Paolucci S, Parisi S, Pecorari M, Pizzi D, Quirino T, Re MC, Rizzardini G, Santangelo R, Soria A, Stazi F, Sterrantino G, Turriziani O, Viscoli C, Vullo V, Lazzarin A, Perno CF; OSCAR Study Group. Svicher V, et al. Among authors: di perri g, di biagio a, di gianbenedetto s, di pietro m. New Microbiol. 2010 Jul;33(3):195-206. New Microbiol. 2010. PMID: 20954437 Free article.
Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens.
Gonzalez de Requena D, Bonora S, Viganò O, Calcagno A, Cometto C, D'Avolio A, Baietto L, Ghisetti V, Magnani S, Ferramosca S, Vitiello P, Galli M, Rusconi S, Di Perri G. Gonzalez de Requena D, et al. Among authors: di perri g. J Antimicrob Chemother. 2011 Jan;66(1):192-200. doi: 10.1093/jac/dkq384. Epub 2010 Oct 29. J Antimicrob Chemother. 2011. PMID: 21037251 Free article.
Ribavirin pharmacokinetics and interleukin 28B plus cytochrome P450 27B1 single-nucleotide polymorphisms as predictors of response to pegylated interferon/ribavirin treatment in patients infected with hepatitis C virus genotype 1/4.
D'Avolio A, Ciancio A, Siccardi M, Baietto L, Simiele M, Cariti G, Calcagno A, Smedile A, Cusato J, Bonora S, Rizzetto M, Di Perri G. D'Avolio A, et al. Among authors: di perri g. Hepatology. 2011 Dec;54(6):2278-9. doi: 10.1002/hep.24636. Hepatology. 2011. PMID: 21898489 No abstract available.
728 results